The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.
Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced promising results from its PoNS Therapeutic Experience Program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback